Post My Press Release

Free Press Release Distribution

Author: neha24bora@gmail.com (Page 1 of 51)

Healthcare Payer BPO Market Global Industry Demand, Future Growth And Forecast 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report Healthcare Payer BPO Market Size & Forecast By Service (Claims Processing Services, Member Services, HR Services, Finance And Accounts) And Trend Analysis From 2012 To 2022

Global Healthcare Payer BPO Market is expected to reach over USD 34.2 billion by 2022 according to a new report by Grand View Research Inc. Key drivers attributing to the growth are ObamaCare, shift to ICD-10 coding system, growing geriatric population, increasing disease burden and penetration of insurance coverage in emerging economies. 

In 2013, as per estimates published by the America’s Health Insurance Plans (AHIP), which is the national trade association representing the health insurance industry, one-sixth of the U.S. economy or nearly USD 2.7 trillion is dedicated to healthcare spending and the number is expected to increase year on year. However, the healthcare system is not able to reap the benefits of such expenditure due to process inefficiencies and use of redundant systems. The estimated loss due to such inefficiencies is nearly 800 billion or approximately 20 to 30 percent of the overall expenditure. 

Increasing healthcare expenditure is a major concern for the U.S. and all the other major economies. In order to reduce the economic burden and provide universal access to healthcare, governments are encouraging outsourcing of payer services to onshore or offshore locations. 

The shift from ICD-9 coding system to ICD-10 coding has created huge work load for the payers to upgrade their systems, train their staff and has significantly increased the financial burden. The ICD-9 code system had 13,000 codes, where as the ICD-10 code system has nearly 68,000 codes. This shift from the legacy system to the latest system has significantly increased the need for medical coding, accounting, HR, and other technical professionals, thereby is expected to positively reinforce the healthcare payer BPO outsourcing market growth in the next seven years. 

Access Research Report of Healthcare Payer BPO Market @ www.grandviewresearch.com/industry-analysis/healthcare-payer-bpo-market

Further key findings from the study suggest:

  • In 2014, claims processing services accounted for the maximum share of approximately 55%. Key reasons attributed are growth in new member enrolments due to ObamaCare, increase in disease burden. For instance, as per data published by ObamaCare and CMS, in 2013 nearly 8 million people enrolled through the marketplace and nearly 11.7 million people were enrolled in 2015.
  • However, Asia Pacific is expected to be the fastest growing market over the forecast period owing to high economic development in the region, favorable government initiatives and growth in insurance penetration across urban and rural centers. For instance, the Indian government’s initiatives such as Pradhan Mantri Suraksha Bima Yojana and Pradhan Mantri Jeevan Jyoti Bima Yojana, are expected to benefit millions of people seeking life insurance and personal accident coverage and as consequence is expected to contribute to the healthcare payer BPO market expansion over the forecast period.
  • Some key players operating in the market include, Xerox Corporation, Genpact Limited, Wipro Limited, Capgemini, Hinduja Global Solutions, HCL Technologies Ltd, Cognizant Technology Solutions, EXLService Holdings Inc., and Accenture. These players dominate the market owing to their strong product and service delivery portfolio, and presence of large customer base in the U.S and European markets.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Healthcare payer BPO market on the basis of services and region:

Global Healthcare Payer BPO Services Outlook (USD Million, 2015 – 2022)

  • Claims Processing Services
  • Member Services
  • HR Services
  • Finance And Accounts

Healthcare Payer BPO Regional Outlook, (USD Million, 2015 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Healthcare Payer BPO Market @ www.grandviewresearch.com/press-release/global-healthcare-payer-bpo-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

High Resolution Melting Analysis Market Expected To Reach USD 131.7 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report High Resolution Melting Analysis Market Size, Share & Trend Analysis Report, By Product (Instruments, Reagents, Software), By Application, By End-use, By Region, And Segment Forecasts, 2012 – 2022

Global High Resolution Melting Analysis Market is expected to reach USD 131.7 billion by 2022 according to a new report by Grand View Research Inc. 

Increasing incidences of cancer, sickle cell anemia, HIV and other STDs are expected to positively reinforce demand for smart and simple molecular diagnostics. According to the Genetic and Rare Diseases Center (GARD) in 2014, 10% of the U.S. population that is nearly 30 million people were suffering from genetic disorders. Some key disease statistics are reported below:

  • As per the estimates provided by CDC, number of acute cases of hepatitis C reported in the United States increased from 1,778 to 2,138 from 2012 to2013
  • According to the UNAIDS report, out of the 36.9 million people that are suffering with HIV/AIDS, 17.1 million are unaware about disease occurrence due to unavailability of testing services
  • As per the WHO estimates in 2015, there are over 130-150 million people suffering with HCV globally 

Based on analyzing the disease trends and relatively lower treatment rates suggests that the demand for gene mutation and other genomic tests are expected to increase significantly over the next few years. Recent developments in the field of QPCR, next generation sequencing, genomics and big data analytics have been instrumental in strengthening the precision medicine approach. The U.S. FDA has already approved some of the treatments which are designed to meet the requirements of a specific genetic makeup or the genomic profile of the patient’s tumor. 

For instance, the U.S FDA has approved a new treatment for cystic fibrosis (CF) in January, 2012. The drug kalydeco was approved for patients reported to have a specific genetic mutation known as “G551D mutation. The number of mutations which can lead to CF is in hundreds, and the G551D mutation is responsible for nearly 4% of the cases in the U.S. 

Furthermore, in 2015, the Obama administration has announced the Precision Medicine Initiative with an investment of USD 216 million in the 2016 president’s budget. This initiative is expected to positively reinforce the HRM analysis market over the forecast period. 

Access Research Report of High Resolution Melting Analysis Market @ www.grandviewresearch.com/industry-analysis/high-resolution-melting-analysis-market

Further key findings from the study suggest:

  • In 2014, North America dominated the overall HRM analysis market with a share of nearly 42%. Key factors attributed are high disease prevalence rates, presence of large number of academic universities; strong pharmaceutical and biotech industry, presence of large number genetic testing centers, and rapid adoption of novel technologies for improving the healthcare outcomes.
  • Asia pacific is identified as the fastest growing region over the forecast period. Key reasons attributed are increasing public and private expenditure on molecular diagnostics and genetic testing, increasing prevalence of genetic disorders, and increasing burden of chronic diseases such as cancer, COPD, HIV and others.
  • Key market players in the High Resolution Melting analysis market include, Roche Molecular Systems, Idaho Technology Corporation, Kapa Biosystems, Thermo Fisher Scientific, Premier Biosoft and Qiagen. Furthermore, Roche Molecular Systems leads the industry with the highest R&D expenditure and commands a significant market share. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the High Resolution Melting analysis market on the basis of product, end-use, application, and region: 

High Resolution Melting Analysis Market Product Outlook, by Revenue (USD Million, 2015 – 2022)

  • Instruments
  • Reagents
  • Software

High Resolution Melting Analysis Market End-Use Outlook, by Revenue (USD Million, 2015 – 2022)

  • Academic Researcher
  • Clinical Diagnostics

High Resolution Melting Analysis Market Application Outlook by Revenue (USD Million, 2015 – 2022)

  • Detection of Acquired Mutations/Mutation Scanning/SNP Typing
  • Microbial Species Identification
  • Zygosity testing
  • Epigenetics/ Methylation Profiling and drug-resistant

High Resolution Melting Analysis Market Regional Outlook, by Revenue (USD Million, 2015 – 2022)

  • North America Product Outlook by Revenue (USD Million), 2012 – 2022
  • Europe Product Outlook by Revenue (USD Million), 2012 – 2022
  • Asia Pacific Product Outlook by Revenue (USD Million), 2012 – 2022
  • Latin America Product Outlook by Revenue (USD Million), 2012 – 2022
  • MEA Product Outlook by Revenue (USD Million), 2012 – 2022

Access Press Release of High Resolution Melting Analysis Market @ www.grandviewresearch.com/press-release/global-high-resolution-melting-analysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

EMEA PoC Diagnostics Market Size Is Anticipated To Reach USD 7.39 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) Diagnostics Market Analysis By Product (Blood Gas/Electrolytes, Infectious Diseases, Hospital Glucose Testing, Cardiac Markers, Hematology, Coagulation, Primary Care Systems, Decentralized Clinical Chemistry, Urinalysis, Drug Abuse Testing, Fertility, OTC, and Rapid Diagnostic Tests) And Segment Forecasts To 2022

The EMEA PoC Diagnostics Market is expected to reach USD 7.39 billion by 2022, according to a new report by Grand View Research Inc. 

Incorporation of healthcare IT and telecommunication such as HealthVault concept by Microsoft plays an inevitable role in the development of the Point-of-Care (PoC) diagnostics market. The introduction of healthcare information systems such as Electronic Medical Records (EMR) has highly increased the market penetration rates of these diagnostic tests. 

Rising demand for home healthcare coupled with patient awareness levels and government initiatives aimed at reducing hospital stays and healthcare expenditure are anticipated to drive the Europe, Middle East, and Africa (EMEA) PoC diagnostics market growth. On account of growing demand for self-testing, companies have launched portable devices that are easy to use such as Pandora CDx point-of-care system by POC Medical Systems. 

Growing base of the geriatric population will widen the target consumer base. Aging heightens the risk of chronic diseases including cardiovascular, diabetes, and cancer. Growing base of geriatric population is anticipated to further increase the demand for continuous monitoring via facilities requiring point-of-care diagnostic products such as home healthcare and assisted living facilities. 

Access Research Report of EMEA PoC Diagnostics Market @ www.grandviewresearch.com/industry-analysis/emea-point-of-care-poc-diagnostics-market

Further key findings from the study suggest:

  • In 2014, glucose testing dominated the EMEA PoC market with a share of over 60%. Growing prevalence of diabetes and the introduction of portable glucose monitoring devices such as OneTouch, Accu-Chek, and Glucotouch are the major drivers for market growth over the forecast period.
  • The infectious disease testing segment is expected to be the fastest-growing product, growing at a CAGR of over8.0% over the next six years. Rising prevalence of infectious disease in low- and middle-income level countries of MEA and Europe is the major aspect accounting for its fastest growth.
  • Clinics are likely to account for over 37% of the market by 2022. High procedure volumes associated with clinical establishments is one of the primary reasons attributing to its huge share.
  • The home healthcare segment, on the other hand, is expected to grow at a lucrative rate during the forecast period owing to its cost-effectiveness and comfort level it provides to the patients
  • Germany held over 19%of the European PoC diagnostics market in 2014.Major factors attributing to growth include the presence of favorable regulations and initiatives undertaken by the government pertaining to the development of healthcare infrastructure and the integration of telecommunications and IT into point-of-care products such as MyGlucoHealth applications.
  • South Africa is expected to be the fastest growing segment over the forecast period. High prevalence of malaria and other febrile infectious diseases coupled with huge population base in South Africa are the major factors driving growth of PoC market in this region
  • Key market players include Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMerieux S.A., and Alere Inc. 

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global EMEA PoC diagnostics market on the basis of product, end-use and region:

EMEA Point-of-Care Diagnostics Product Outlook (Revenue, USD Million, 2015 – 2022)

  • Glucose testing
    • Over The Counter (OTC)
    • Prescribed
    • Cardiac markers
    • Fertility
    • Blood gas and electrolytes
    • Decentralized clinical chemistry
    • Infectious disease testing
    • CoagulationPrimary care systems
      • Over The Counter (OTC)
      • Prescribed
    • Hematology
    • Urinalysis
    • Drug abuse testing
    • Others

EMEA Point-of-Care Diagnostics End-Use Outlook (Revenue, USD Million, 2015 – 2022)

  • Hospitals
  • Clinics
  • Laboratories
  • Assisted living healthcare facilities
  • Others

EMEA Point-of-Care Diagnostics Regional Outlook (Revenue, USD Million, 2015 – 2022)

  • Europe
  • MEA

Access Press Release of EMEA PoC Diagnostics Market @ www.grandviewresearch.com/press-release/emea-poc-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cancer Supportive Care Drugs Market Determined To Reach USD 23.5 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report  Cancer Supportive Care Drugs Market Analysis Report By Therapeutic Class (G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs), By Major Markets, Vendor Landscape, And Segment Forecasts, 2016 – 2022

The global Cancer Supportive Care Drugs Market size is expected to be valued at USD 23.5 billion by 2022, as per a new report by Grand View Research, Inc., progressing at a CAGR of 1.8% during the forecast period. The market is anticipated to be driven by large number of side-effects associated with cancer treatment, increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored treatments.

Chemotherapy and radiotherapy are traditional methods for cancer treatment with approximately four million people receiving chemotherapy every year. Supportive care products are essential to prevent and manage symptoms and side-effects of cancer and its treatment.Among major cancer types, lung and breast cancers are the most prominent cancer type with the highest demand for supportive care drugs.

G-CSFs and ESAs therapeutic classes are witnessing a fundamental shift from biologics to biosimilars. The market for cancer pain, chemotherapy induced nausea and vomiting, and cancer induced bone diseases will grow significantly during the forecast period, due to new product launches and high unmet needs. The cancer pain market is estimated to witness a shift from opioids to non-opioids therapies. The shift will be backed by patent loss, high mortality, addiction, and major safety issues associated with narcotic agents.

Access Research Report of Cancer Supportive Care Drugs Market @  www.grandviewresearch.com/industry-analysis/cancer-supportive-care-drugs-market

Further key findings from the report suggest:

  • Some of the key players operating in this industry are Amgen, Johnson & Johnson, Merck, Roche, Helsinn Healthcare, Heron Pharma, and Tesaro
  • Among EU5, Germany captured the second position in the global cancer support care drugs market. Japan is poised to witness the fastest growth over the forecast period
  • The CINV drugs market will be propelled by widening base of patients, increasing adoption of chemotherapeutic drugs, and launch of new drug delivery approaches to improve patient compliance
  • In Europe, Zarzio has taken over its reference product Neupogen in terms of market share
  • Late stage pipeline products include non-opioids such as Tanezumab and HTX-011
  • Newer immunotherapies directed against PD-1 ligands and PD-L1 proteins have shown to be more effective with a superior safety profile

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the global cancer supportive care drugs market based on drug class and treatment:

Cancer Supportive Care Drugs Therapeutic Class Outlook (Revenue, USD Million, 2016 – 2022)

  • G-CSFs
  • ESAs
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs and others

Cancer Supportive Care Drugs Regional Outlook (Revenue, USD Million, 2016 – 2022)

  • U.S.
  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Japan

Access Press Release of Cancer Supportive Care Drugs Market @ www.grandviewresearch.com/press-release/global-cancer-supportive-care-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Steam Autoclaves Market Industry Size ,Share And Forecast Till 2022 : Grand View Research Inc.

San Francisco, 15 May 2019: The Report Steam Autoclaves Market Analysis By Configuration (Table Top, Vertical, Horizontal, Floor Standing, High Pressure), By Application (Medical, Dental, Laboratory) And Segment Forecasts To 2022

The global Steam Autoclaves Market is expected to reach USD 2.89 billion by 2022, according to a new study by Grand View Research, Inc. Growing demand for disinfection and sterilization is expected to drive the demand for steam autoclaves in laboratory and medical settings. Medical & biohazardous waste management applications are anticipated to experience a rapid growth in demand owing to increasing implementation and acceptance rates of biosafety guidelines.

Furthermore, increasing incidence rates of hospital acquired infections and growing need for safe management of infectious medical waste are expected to drive the steam autoclaves market over the forecast period. Rising number of government regulations aimed at the mandatory implementation of biosafety regulations, growing demand for portable autoclaves and the introduction of cost-effective devices are expected to serve the steam autoclaves market as future growth opportunities.

Access Research Report of Steam Autoclaves Market @ www.grandviewresearch.com/industry-analysis/steam-autoclave-market

Further key findings from the study suggest:

  • Vertical steam autoclaves were the largest product segment in 2014. This large share can be accounted for by the presence of a wide product range, available in the market including medium range medical & laboratory autoclaves. Moreover, the availability of specialized medical and bio-hazardous waste management devices is expected to drive segment growth over the forecast period.
  • Medical waste management and sterilization was the largest application of the market in 2014 owing to, the presence of a comparatively higher demand for sterilization and disinfection in hospitals and clinics. Moreover, due to the growing demand for pharmaceutical bio-hazardous waste management and the gradually increasing levels of generation of such waste, it is expected that the laboratory applications of specialized autoclaves for bio-hazardous and solid waste management is expected to grow at a rapid rate over the forecast period.
  • North America accounted for the largest share of the market in 2014 at over 40.0%. Growing prevalence of hospital acquired infection and the presence of large procedure volumes and stringent government regulations are some key factors expected to drive regional market growth during the forecast period.
  • Asia Pacific is identified as the fastest growing regional steam autoclaves market. Presence of untapped opportunities in the emerging markets of India and China is expected to serve manufacturers with lucrative future growth opportunities. Moreover, growing demand for medical tourism in the region is expected to improve device usage rates by heightening the need for sophisticated medical infrastructure.
  • Key players of the steam autoclaves market include Tuttnauer, Matachana, BMM Weston, Getinge Infection Control, LTE Scientific, Belimed Deutschland, Medisafe International, Panasonic, Priorclave and Eryigit Medical Devices Steris

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the steam autoclaves market on the basis of configuration, application and region:

Global Steam Autoclaves Market, Configuration Outlook (Revenue, USD Million, 2012 – 2022)

  • Table Top Autoclaves
  • Vertical Steam Autoclaves
  • Horizontal Steam Autoclaves
  • Floor Standing Steam Autoclaves
  • High pressure Steam Autoclaves

Global Steam Autoclaves Market, Application Outlook (Revenue, USD Million, 2012 – 2022)

  • Medical Steam Autoclaves
    • Hospital Steam Autoclaves
    • Clinical Steam Autoclaves
    • Medical Waste Management Steam Autoclaves
  • Dental Steam Autoclaves
  • Laboratory Steam Autoclaves
    • Pharmaceutical Steam Autoclaves
    • Bio-hazardous Waste Management Steam Autoclaves

Steam Autoclaves Market, Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Steam Autoclaves Market @ www.grandviewresearch.com/press-release/global-steam-autoclaves-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Image-guided Therapy Systems Market Latest Innovations, Drivers and Industry Key Events by 2025: Grand View Research Inc.

San Francisco,17 June 2019: The Report  Image-guided Therapy Systems Market Size, Share & Trends Analysis Report By End Use (ASCs, Clinics, Hospitals), By Product (MRI, PET), By Application (Neurosurgery, Urology), And Segment Forecasts, 2018 – 2025

The global image-guided therapy systems market size is expected to reach USD 4.95 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to exhibit a healthy CAGR of 6.3% during the forecast period. Growing geriatric population base and cases of chronic diseases are expected to boost the market demand. Other factors propelling the market growth include rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy is also one of the important factors driving the market.

New product launches by major companies is also having a positive impact on the market development. For instance, in February 2017, Philips launched a next-generation image guided therapy platform called Azurion for advancing patient care. Growing adoption of such advanced systems is expected to drive the market. Development of this system was aimed at optimizing interventional lab performance, thereby ensuring superior care delivery. Increasing number of initiatives undertaken by public and private firms in the area of cancer radiotherapy is also estimated to have a positive impact on the market growth.

In addition, many academic institutions are also investing in cancer radiotherapy projects for increasing the effectiveness of treatment therapies. This is also likely to contribute toward market expansion. The development of Image-guided Therapy Program by the Brigham and Women’s Hospital aimed at advancing imaging and therapeutic technologies for developing minimally invasive surgical and interventional techniques is an example of one such initiative.

Access Research Report of Image-guided Therapy Systems Market @ www.grandviewresearch.com/industry-analysis/image-guided-therapy-systems-market

Further key findings from the study suggest:

  • Endoscopes segment accounted for the largest revenue share in 2017 owing to technological advancements, high volume of endoscope-guided surgeries, and rising preference for minimally invasive surgeries
  • Cardiac surgery emerged as the largest application segment in 2017. This growth is attributed to rising prevalence of target diseases, preference for minimally invasive cardiac surgeries, and R&D initiatives aimed at developing real-time cardiac interventions systems
  • Hospitals emerged as the largest end-use segment in 2017. However, Ambulatory Surgery Centers (ASCs) segment is projected to expand at the fastest CAGR of 7.3% over the forecast period
  • North America emerged as the largest regional market. Asia Pacific is anticipated to exhibit the fastest growth rate of 7.6% during the forecast period
  • The market is consolidated with the presence of Koninklijke Philips N.V., Siemens Healthineers, GE Healthcare, and Fujifilm Holdings Corporation accounting for the majority market share. Analogic Corporation; Varian Medical Systems, Inc.; Brainlab AG; Medtronic PLC; and Stryker Corp. are several other prominent companies in the market.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global image-guided therapy systems market on the basis of product, application, end use, and region:

Image-guided Therapy Systems Product Outlook (Revenue, USD Million, 2014 – 2025)

  • Computed Tomography (CT) Scanners
  • Ultrasound Systems
  • Magnetic Resonance Imaging (MRI)
  • Endoscope
  • X-ray Fluoroscopy
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)

Image-guided Therapy Systems Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Cardiac Surgery
  • Neurosurgery
  • Orthopedic Surgery
  • Urology
  • Gastroenterology
  • Oncology Surgery
  • Others

Image-guided Therapy Systems End-use Outlook (Revenue, USD Million, 2014 – 2025)

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Research & Academic Institutes

Image-guided Therapy Systems Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Access Press Release of Image-guided Therapy Systems Market@ www.grandviewresearch.com/press-release/global-image-guided-therapy-systems-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Smart Healthcare Market Accounted For USD 225.54 Billion By 2022 : Grand View Research Inc.

San Francisco, 15 May 2019: The Report Smart Healthcare Market Analysis by Product (RFID Kanban Systems, RFID Smart Cabinets, Electronic Health Records/EHR, Telemedicine, mHealth, Smart Pills, Smart Syringes) And Segment Forecasts To 2022

Global Smart Healthcare Market is expected to reach USD 225.54 Billion by 2022, according to a new study by Grand View Research, Inc. Rapid technological advancements in healthcare IT is expected to remain a key driving factor of the global smart healthcare market over the forecast period. Growing implementation of inventory management systems such as RFID KanBan and RFID smart cabinets aimed at curbing inventory costs and ensure appropriate logistics management is expected to boost the growth of the smart healthcare market. Development of smart syringes, smart pills and smart bandages which enable remote monitoring of patients, help in diagnosing gastrointestinal diseases and infection spread minimization and remote monitoring of healing processes is expected to strengthen the platform for future market growth. On the other hand, high capital investments and poor awareness levels among consumers are some challenges faced by manufacturers.

mHealth is expected to register the fastest growth of over 40.0% over the forecast period.  Key factors likely to drive segment growth include rapidly increasing incidence rates of chronic diseases, increasing smart phone penetration rates and heightening need to ensure improved healthcare outcomes.

Access Research Report of Smart Healthcare Market @ www.grandviewresearch.com/industry-analysis/smart-healthcare-market

Further key findings from the study suggest:

  • Electronic health record (EHR) emerged as the largest product segment in terms of revenue and was estimated at over USD 19.50 billion in 2014. Implementation of the American Recovery and Reinvestment Act (ARRA) and HITECH Act is expected to make significant contributions towards segment growth. Key feature of HITECH Act includes the provision of USD 64,000 per year to healthcare practitioners adopting EHR systems.
  • North America was the largest smart healthcare regional market in 2014. Presence of favorable government initiatives in the form of HITECH Act providing allowances to healthcare practitioners is one of the major factors expected to drive regional market growth. Presence of sophisticated IT infrastructure enabling easy implementation of advanced healthcare facilities is also expected to boost market growth over the forecast period.
  • Asia Pacific is expected to grow at a considerable pace over the forecast period owing to growing penetration of advanced healthcare facilities and rapidly evolving mobile & IT infrastructure. Increasing awareness among consumers pertaining to novel healthcare technologies such as telemedicine, mHealth and EHR is expected to further complement regional market growth.
  • Key players operating in the smart healthcare market include Cisco, IBM, Olympus Corp., GE Healthcare, AT&T Inc., Apple Inc., Samsung Electronics, Logi-Tag, Wurth Group, AirStrip Technologies Inc., Allscripts Healthcare Solutions Inc., Pepperl+Fuchs and Given Imaging Inc.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the smart healthcare market on the basis of product, and region:

Global Smart Healthcare Product Outlook (Revenue, USD Million, 2014 – 2022)

  • RFID KanBan systems
  • RFID smart cabinets
  • Electronic Health Records (EHR)
    • Client-server based
    • Web-based
  • Telemedicine
    • Hardware
    • Connectivity and network
    • Others
  • mHealth
    • Monitoring services
    • Diagnosis services
    • Healthcare systems
    • Others
  • Smart pills
  • Smart syringes

Smart Healthcare  Regional Outlook (Revenue, USD Million, 2014 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • MEA
  • Latin America

Access Press Release of Smart Healthcare Market @ www.grandviewresearch.com/press-release/global-smart-healthcare-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Aminoglycosides Market Is Likely To Up Demand At A USD 1.68 Billion By 2022 : Grand View Research Inc.

San Francisco, 14 May 2019: The Report Aminoglycosides Market Analysis By Drug (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin), By Mode of Administration (Feed, Injectables (Parenteral), Intra-mammary, Topical, Oral), By Application (Veterinary, Skin, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis) And Segment Forecasts To 2022

Global Aminoglycosides Market is expected to reach USD 1.68 billion by 2022 growing at an estimated CAGR of 3.5% from 2015 to 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the increasing incidences of animal disease outbreaks leading to high utilization of antibiotics. 

However, reduction in prescription rate of aminoglycoside antibiotics due to side effects associated with usage of these drugs that include severe ototoxicity, nephrotoxicity, and neuromuscular blockade are expected to affect the market growth negatively. Furthermore, regulatory disapproval for the usage of certain aminoglycoside in regions is also anticipated to attribute for subordinate growth in this industry. 

Access Research Report of Aminoglycosides Market @ www.grandviewresearch.com/industry-analysis/aminoglycoside-market

Further key findings from the report suggest:

  • Neomycin and tobramycin together contributed for over USD 600 million as revenue in this market owing to higher usage and prescription of these drugs for treatment of different bacterial infections. Neomycin finds higher usage in topical formulations for treatment of different skin infections.
  • Injectables accounted for the largest share of revenue amongst other routes of administration owing to higher usage for treatment of tuberculosis, MDR-TB, and XDR-TB. Use of second line anti tuberculosis drugs such as kanamycin & capreomycin by global organizations is attributive for generation of maximum revenue in this segment.
  • Human use for treatment of respiratory disorders accounted for largest share in applications segment owing to rise in global incidence of tuberculosis. Furthermore, other bacterial infections of respiratory tract that can be treated using aminoglycoside class of antibiotics are anticipated to contribute for expected growth in this segment.
  • Veterinary treatment is expected to boost industrial growth in the coming years owing to higher incidence of animal diseases outbreaks. However, these drugs have restrictive regulations for administration to food-producing animals as it may lead to toxic effects and resistance development on humans after consumption of animal originated food.
  • Asia Pacific was the largest market, accounting for over 40% of revenue in aminoglycoside industry owing to, the presence of market players in this region coupled with higher rate of tuberculosis incidences herein.
  • South Africa spearheaded growth in the MEA market. The presence of relatively higher demand and consumption of injectable solutions in this region because of increase in incidence rate of MDR-TB and other drug resistant infections are some regional growth drivers.
  • Key participants of the aminoglycoside market include Vega Pharma Ltd., Kremoint Pharma Pvt. Ltd, Xian Wison Biological Technology Co., Ltd., Jiangxi Bolai Pharmacy Co., Ltd., Medson Pharmaceuticals, Hangzhou Uniwise International Co., Ltd., Yi Chang Veterinary Medicine Factory, HuvePharma, and Medico Remedies Pvt. Ltd.
  • Market players are involved in the development of products with newer formulations and lesser side effects in order to treat eradicate bacterial infections that are resistant to other class of antibiotics.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented aminoglycoside market on the basis of product, route of administration, application, and region:

Aminoglycoside Product Outlook (Market Revenue in USD Million, 2012 – 2022 )

  • Neomycin
  • Tobramycin
  • Gentamicin
  • Amikacin
  • Paromomycin
  • Streptomycin
  • Kanamycin
  • Others

Aminoglycoside Outlook, by Route of Administration (Market Revenue in USD Million, 2012 – 2022)

  • Injectables
  • Feed
  • Intra-mammary
  • Topical
  • Oral

Aminoglycoside Application Outlook (Market Revenue in USD Million, 2012 – 2022)

  • Veterinary
  • Skin Infection
  • Respiratory diseases
  • UTI & Pelvic Diseases
  • Other diseases

Aminoglycoside Regional Outlook (Revenue, USD Million, 2012 – 2022)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Aminoglycosides Market @ www.grandviewresearch.com/press-release/global-aminoglycoside-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Page 1 of 51

Powered by WordPress & Theme by Anders Norén